Metis TechBio Co (HKSE:07666) Interest Coverage: 0 (At Loss) (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:07666 Metis TechBio Co Ltd HKSE:07666
6 GF Score
Price HK$12.24
! 1 Warning Sign
View Full Analysis

What is Metis TechBio Co Interest Coverage?

Metis TechBio Co HKSE:07666 +2.00% 6 Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus rates HKSE:07666 with a GF Score™ of 6/100. The stock has 1 warning sign investors should review. Among 372 Biotechnology companies, Metis TechBio Co ranks worse than 268816.94% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Metis TechBio Co's Operating Income for the three months ended in Dec. 2025 was HK$-157.24 Mil. Metis TechBio Co's Interest Expense for the three months ended in Dec. 2025 was HK$-1.23 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Metis TechBio Co's Interest Coverage or its related term are showing as below:


HKSE:07666's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.135
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Metis TechBio Co  (HKSE:07666) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Metis TechBio Co Interest Coverage Related Terms


Metis TechBio Co Interest Coverage Historical Data

* Premium members only.

The historical data trend for Metis TechBio Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Metis TechBio Co Interest Coverage Chart

Metis TechBio Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Interest Coverage
0.00 0.00 0.00 0.00

Metis TechBio Co Quarterly Data
Dec22 Dec23 Dec24 Sep25 Dec25
Interest Coverage N/A N/A 0.00 N/A 0.00

HKSE:07666 vs VRTX, REGN, RVMD: Interest Coverage Comparison

For the Biotechnology subindustry, Metis TechBio Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metis TechBio Co Interest Coverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Metis TechBio Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Metis TechBio Co's Interest Coverage falls into.


HKSE:07666
6GF Score
Metis TechBio Co Ltd HKSE:07666
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metis TechBio Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Metis TechBio Co's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Metis TechBio Co's Interest Expense was HK$-35.14 Mil. Its Operating Income was HK$-391.09 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$79.71 Mil.

Metis TechBio Co did not have earnings to cover the interest expense.

Metis TechBio Co's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Here, for the three months ended in Dec. 2025, Metis TechBio Co's Interest Expense was HK$-1.23 Mil. Its Operating Income was HK$-157.24 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$79.71 Mil.

Metis TechBio Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Metis TechBio Co (HKSE:07666) has a Interest Coverage of 0 (At Loss) as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Metis TechBio Co and its competitors. According to the industry distribution chart, Metis TechBio Co ranks #999999 out of 372 companies in the Biotechnology industry.
Is Metis TechBio Co's Interest Coverage too high?
Metis TechBio Co's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Metis TechBio Co ranks #999999 out of 372 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Metis TechBio Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Metis TechBio Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Metis TechBio Co ranks #999999 out of 372 companies for Interest Coverage. This places Metis TechBio Co in the lower half of its industry. The industry median Interest Coverage is 106.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.14, based on 372 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Metis TechBio Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metis TechBio Co's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metis TechBio Co stock overvalued right now?
Metis TechBio Co (HKSE:07666) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Metis TechBio Co's overall GF Score™ is 6/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Metis TechBio Co (HKSE:07666), the current Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metis TechBio Co Business Description

Other Exchanges RO9:Germany
Address No. 21 Tianhe West Road, Room 201, 2nd Floor, Building 13, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing, CHN
Metis TechBio Co Ltd is an investment holding company. The company and its subsidiaries are principally engaged in AI-empowered nanomaterial innovation for the delivery and application of active agents across all carbon-based life forms. Its technology platform, NanoForge, comprises a set of integrated tools, including a lipid library, AI models, an AI agent (METiS), quantum chemistry and molecular dynamics simulations, and high-throughput screening platforms. The company has developed three solution platforms (AiTEM, AiLNP, and AiRNA) designed to simulate, predict, and interpret nanoscale interactions, enabling the rational design, optimization, and validation of nanomaterials and their associated payloads.
6GF Score

Get the complete analysis for HKSE:07666

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.24
Price